Amerise Biosciences Ltd
Amerise Biosciences Ltd (AMERISE) last traded at ₹0.83, a market capitalisation of ₹5.48 crore. Over the past 52 weeks the stock has ranged between ₹0.5 and ₹1.03. Amerise Biosciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹-0.08 crore. Figures are as of 25 Aug 2026 and are not real time.
Amerise Biosciences Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Amerise Biosciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹0 cr, down 100.0% from ₹0.06 cr a year earlier. Net profit was ₹-0.08 cr, down 700.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0.19 | 0.06 | 0.07 | 0.04 | 0.08 | 0 |
| Expenses | 0.03 | 0.02 | 0.08 | 0.07 | 0.11 | 0.03 | 0.02 | 0.08 |
| Operating profit | -0.03 | -0.02 | 0.11 | -0.01 | -0.04 | 0.01 | 0.06 | -0.08 |
| OPM % | — | — | 57.89% | -16.67% | -57.14% | 25.00% | 75.00% | — |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.03 | -0.02 | 0.11 | -0.01 | -0.04 | 0.01 | 0.06 | -0.08 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | -0.03 | -0.02 | 0.11 | -0.01 | -0.04 | 0.01 | 0.06 | -0.08 |
| EPS (₹) | -0.00 | -0.00 | 0.02 | -0.00 | -0.01 | 0.00 | 0.01 | -0.01 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Amerise Biosciences Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 9.58 | 0.01 | 0.04 | 0.19 | 0.26 | 0.19 |
| Operating profit | -0.17 | 0.55 | -0.12 | -0.15 | 0.01 | 0.02 | -0.05 |
| OPM % | — | 5.74% | -1,200.00% | -375.00% | 5.26% | 7.69% | -26.32% |
| Net profit | -0.34 | 0.55 | -0.12 | -0.15 | 0.01 | 0.02 | -0.05 |
| EPS (₹) | -0.05 | 0.08 | -0.02 | -0.02 | 0.00 | 0.00 | -0.01 |
TTM is the trailing twelve months to the most recent quarter.
Amerise Biosciences Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 196%
- TTM
- -24%
- 10 Years
- 10%
- 5 Years
- 16%
- 3 Years
- 29%
- TTM
- -200%
- 10 Years
- -6%
- 5 Years
- -10%
- 3 Years
- 8%
- 1 Year
- 15%
- 10 Years
- -2%
- 5 Years
- 1%
- 3 Years
- -1%
- Last Year
- 0%
Amerise Biosciences Ltd shareholding pattern
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Public | 100.00% | 100.00% | 100.00% | 99.99% | 100.00% | 99.99% | 100.00% | 100.00% |
| No. of shareholders | 27,077 | 35,142 | 36,595 | 36,217 | 35,676 | 35,180 | 34,519 | 33,848 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Amerise Biosciences Ltd corporate filings
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Snehjeev Ventures Pvt Ltd & PACsInsider Trading / SASTmedium impact
Cruxal's analysis: Snehjeev Ventures Pvt. Ltd., along with Persons Acting in Concert (PAC), has acquired…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Amerise Biosciences Ltd
Cruxal reads every Amerise Biosciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.